The acquisition of Catapult Health by Teladoc Health is a strategic move to enhance its service offerings in at-home diagnostics. This could lead to improved early detection of health conditions, potentially increasing Teladoc's market share and revenue. The $65 million investment indicates a significant commitment to expanding capabilities, which is likely to positively impact Teladoc's stock price in the short term.